Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Alzheimer'S Research & Therapy
|
August 18, 2023
Feasibility and therapeutical potential of local intracerebral encapsulated cell biodelivery of BDNF to App<sup>NL-G-F</sup> knock-in Alzheimer mice
Simone Tambaro, Sumonto Mitra, Ruchi Gera, et al.
Life Sciences
|
March 27, 2019
Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment
Marika Premoli, Francesca Aria, Sara Anna Bonini, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 29, 2003
Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor
Stefania Ruiu, Gèrard A Pinna, Giorgio Marchese, et al.
Brain Communications
|
January 23, 2023
Translational potential of synaptic alterations in Alzheimer's disease patients and amyloid precursor protein knock-in mice
Dina Medina-Vera, Daniela Enache, Simone Tambaro, et al.
Journal of Psychiatric Research
|
June 3, 2014
The aggression and behavioral abnormalities associated with monoamine oxidase A deficiency are rescued by acute inhibition of serotonin reuptake
Sean C Godar, Marco Bortolato, M Paola Castelli, et al.
Biology
|
June 28, 2023
The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer's Disease in <i>App</i> Knock-In Mice
Dina Medina-Vera, Hongjing Zhao, Erika Bereczki, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 17, 2026
D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease
Beatriz Pacheco-Sánchez, Antonio J López-Gambero, Ana Luisa Gavito, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Andrea Mosqueda Solis, Simone Tambaro, Bowen Tang, et al.
Molecular Psychiatry
|
August 13, 2021
Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the App<sup>NL-G-F</sup> mouse model of Alzheimer's disease
Luis Enrique Arroyo-García, Arturo G Isla, Yuniesky Andrade-Talavera, et al.
Communications Biology
|
January 22, 2020
Augmentation of Bri2 molecular chaperone activity against amyloid-β reduces neurotoxicity in mouse hippocampus in vitro
Gefei Chen, Yuniesky Andrade-Talavera, Simone Tambaro, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Alzheimer'S Research & Therapy
|
August 18, 2023
Feasibility and therapeutical potential of local intracerebral encapsulated cell biodelivery of BDNF to App<sup>NL-G-F</sup> knock-in Alzheimer mice
Simone Tambaro, Sumonto Mitra, Ruchi Gera, et al.
Life Sciences
|
March 27, 2019
Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment
Marika Premoli, Francesca Aria, Sara Anna Bonini, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 29, 2003
Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor
Stefania Ruiu, Gèrard A Pinna, Giorgio Marchese, et al.
Brain Communications
|
January 23, 2023
Translational potential of synaptic alterations in Alzheimer's disease patients and amyloid precursor protein knock-in mice
Dina Medina-Vera, Daniela Enache, Simone Tambaro, et al.
Journal of Psychiatric Research
|
June 3, 2014
The aggression and behavioral abnormalities associated with monoamine oxidase A deficiency are rescued by acute inhibition of serotonin reuptake
Sean C Godar, Marco Bortolato, M Paola Castelli, et al.
Biology
|
June 28, 2023
The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer's Disease in <i>App</i> Knock-In Mice
Dina Medina-Vera, Hongjing Zhao, Erika Bereczki, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 17, 2026
D-chiro-inositol modulates brain insulin-related signaling and reduces amyloid burden, neuroinflammation and cognitive decline in preclinical models of Alzheimer's disease
Beatriz Pacheco-Sánchez, Antonio J López-Gambero, Ana Luisa Gavito, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Drug Development
Andrea Mosqueda Solis, Simone Tambaro, Bowen Tang, et al.
Molecular Psychiatry
|
August 13, 2021
Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the App<sup>NL-G-F</sup> mouse model of Alzheimer's disease
Luis Enrique Arroyo-García, Arturo G Isla, Yuniesky Andrade-Talavera, et al.
Communications Biology
|
January 22, 2020
Augmentation of Bri2 molecular chaperone activity against amyloid-β reduces neurotoxicity in mouse hippocampus in vitro
Gefei Chen, Yuniesky Andrade-Talavera, Simone Tambaro, et al.
Page
of 5